Table of Contents:@0.222971:0.815978:0.222971:0.190784:0.060223:0.190784:0.060223:0.815978:0.067639:-0.104928:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.921491
A Multinational Study On The Factors Influencing University Students’ Attitudes :@0.311647:0.062263:0.862551:0.062263:0.862551:0.046264:0.311647:0.046264:0.011205:0.004200:0.014934:0.008399:0.004670:0.004670:0.004670:0.008399:0.007459:0.004670:0.004670:0.008399:0.008399:0.007459:0.004670:0.004200:0.009340:0.004670:0.008399:0.008399:0.008399:0.004200:0.012129:0.008399:0.003879:0.010264:0.008399:0.007459:0.004200:0.009340:0.007459:0.007459:0.004670:0.008399:0.005594:0.006535:0.004200:0.005594:0.008399:0.005594:0.004670:0.008399:0.007459:0.008399:0.007459:0.004670:0.008399:0.008399:0.004200:0.012129:0.008399:0.004670:0.008399:0.007459:0.005594:0.006535:0.004670:0.004670:0.008399:0.004200:0.009340:0.004670:0.008399:0.008399:0.007459:0.008399:0.004670:0.006535:0.004321:0.003274:0.012129:0.004670:0.004670:0.004670:0.004670:0.008399:0.008399:0.007459:0.006535:0.004200
And Usage Of ChatGPT:@0.311647:0.076517:0.476343:0.076517:0.476343:0.060517:0.311647:0.060517:0.012129:0.008399:0.008399:0.004200:0.012129:0.006535:0.007459:0.008399:0.007459:0.004200:0.012129:0.005594:0.004200:0.011205:0.008399:0.007459:0.004670:0.012129:0.009340:0.010264
96:@0.896299:0.070167:0.914778:0.070167:0.914778:0.052567:0.896299:0.052567:0.009239:0.009239
Comparative Novel Green Reversed-Phase High-Performance Liquid :@0.311647:0.098066:0.782840:0.098066:0.782840:0.082066:0.311647:0.082066:0.011205:0.008399:0.013070:0.008399:0.007459:0.005594:0.007459:0.004670:0.004670:0.008399:0.007459:0.004200:0.012129:0.008399:0.008399:0.007459:0.004670:0.004200:0.012129:0.005594:0.007459:0.007459:0.008399:0.004200:0.011205:0.007459:0.008399:0.007459:0.005594:0.006535:0.007459:0.008399:0.005594:0.009340:0.008399:0.007459:0.006535:0.007459:0.004200:0.012129:0.004670:0.008399:0.008399:0.005594:0.009340:0.007459:0.005594:0.005594:0.008399:0.005594:0.013070:0.007459:0.008399:0.007459:0.007459:0.004200:0.010264:0.004670:0.008399:0.008399:0.004670:0.008399:0.004200
Chromatography Method For Simultaneous Determination Of Ivabradine And :@0.311647:0.112319:0.840712:0.112319:0.840712:0.096320:0.311647:0.096320:0.011205:0.008399:0.005594:0.008399:0.013070:0.007459:0.004670:0.008399:0.008399:0.005594:0.007459:0.008399:0.008399:0.008399:0.004200:0.014934:0.007459:0.004670:0.008399:0.008399:0.008399:0.004200:0.009340:0.008399:0.005594:0.004200:0.009340:0.004670:0.013070:0.008399:0.004670:0.004670:0.007459:0.008399:0.007459:0.008399:0.008399:0.006535:0.004200:0.012129:0.007459:0.004670:0.007459:0.005594:0.013070:0.004670:0.008399:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.012129:0.005594:0.004200:0.005594:0.008399:0.007459:0.008399:0.005594:0.007459:0.008399:0.004670:0.008399:0.007459:0.003225:0.012129:0.008399:0.008399:0.004200
Carvedilol In Tablets And Human Plasma Using UV And Fluorescence Detectors:@0.311647:0.126573:0.857602:0.126573:0.857602:0.110573:0.311647:0.110573:0.011205:0.007459:0.005594:0.008399:0.007459:0.008399:0.004670:0.004670:0.008399:0.004670:0.004200:0.005594:0.008399:0.003882:0.009088:0.007459:0.008399:0.004670:0.007459:0.004670:0.006535:0.003266:0.012129:0.008399:0.008399:0.004200:0.012129:0.008399:0.013070:0.007459:0.008399:0.004200:0.009340:0.004670:0.007459:0.006535:0.013070:0.007459:0.004200:0.012129:0.006535:0.004670:0.008399:0.008399:0.004200:0.012129:0.011828:0.003272:0.012129:0.008399:0.008399:0.004200:0.009340:0.004670:0.008399:0.008399:0.005594:0.007459:0.006535:0.007459:0.007459:0.008399:0.007459:0.007459:0.004200:0.012129:0.007459:0.004670:0.007459:0.007459:0.004670:0.008399:0.005594:0.006535
97:@0.896299:0.113096:0.914778:0.113096:0.914778:0.095496:0.896299:0.095496:0.009239:0.009239
Efficacy Of Montelukast As An Adjuvant Therapy In Rheumatoid  Arthritis :@0.311647:0.148122:0.822855:0.148122:0.822855:0.132122:0.311647:0.132122:0.010264:0.005288:0.005594:0.004670:0.007459:0.007459:0.007459:0.008399:0.004200:0.012129:0.005594:0.004200:0.014934:0.008399:0.008399:0.004670:0.007459:0.004670:0.008399:0.008399:0.007459:0.006535:0.004670:0.003257:0.012129:0.006535:0.003277:0.012129:0.008399:0.003276:0.012129:0.008399:0.004670:0.008399:0.008399:0.007459:0.008399:0.004670:0.003891:0.010264:0.008399:0.007459:0.005594:0.007459:0.008399:0.008399:0.004200:0.005594:0.008399:0.004200:0.011205:0.008399:0.007459:0.008399:0.013070:0.007459:0.004670:0.008399:0.004670:0.008399:0.004200:0.003252:0.012129:0.005594:0.004670:0.008399:0.005594:0.004670:0.004670:0.004670:0.006535:0.004200
Patients: A Randomized Controlled Study:@0.311647:0.162376:0.592577:0.162376:0.592577:0.146376:0.311647:0.146376:0.009340:0.007459:0.004670:0.004670:0.007459:0.008399:0.004670:0.006535:0.004670:0.003262:0.011203:0.004200:0.011205:0.007459:0.008399:0.008399:0.008399:0.013070:0.004670:0.007459:0.007459:0.008399:0.004200:0.011205:0.008399:0.008399:0.004670:0.005594:0.008399:0.004670:0.004670:0.007459:0.008399:0.004200:0.009340:0.004670:0.008399:0.008399:0.008399
98:@0.896299:0.156025:0.914778:0.156025:0.914778:0.138426:0.896299:0.138426:0.009239:0.009239
Evaluation Of Knowledge, Experiences, And Fear Toward Prescribing And :@0.311647:0.182241:0.821000:0.182241:0.821000:0.166241:0.311647:0.166241:0.010264:0.008399:0.007459:0.004670:0.008399:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.012129:0.005594:0.004200:0.012129:0.008399:0.008399:0.012129:0.004670:0.007459:0.008399:0.008399:0.007459:0.004200:0.004200:0.010264:0.008399:0.008399:0.007459:0.005594:0.004670:0.007459:0.008399:0.007459:0.007459:0.006535:0.004200:0.003244:0.012129:0.008399:0.008399:0.004200:0.009340:0.007459:0.007459:0.005594:0.003897:0.009088:0.008399:0.012129:0.007459:0.005594:0.008399:0.004200:0.009340:0.005594:0.007459:0.006535:0.007459:0.005594:0.004670:0.008399:0.004670:0.008399:0.008399:0.003267:0.012129:0.008399:0.008399:0.004200
Dispensing Corticosteroids Among Egyptian Healthcare Professionals: A Cross-:@0.311647:0.196495:0.850544:0.196495:0.850544:0.180495:0.311647:0.180495:0.012129:0.004670:0.006535:0.008399:0.007459:0.008399:0.006535:0.004670:0.008399:0.008399:0.004200:0.011205:0.008399:0.005594:0.004670:0.004670:0.007459:0.008399:0.006535:0.004670:0.007459:0.005594:0.008399:0.004670:0.008399:0.006535:0.003262:0.012129:0.013070:0.008399:0.008399:0.008399:0.004200:0.010264:0.008399:0.008399:0.008399:0.004670:0.004670:0.007459:0.008399:0.004200:0.012129:0.007459:0.007459:0.004670:0.004670:0.008399:0.007459:0.007459:0.005594:0.007459:0.004200:0.009340:0.005594:0.008399:0.005594:0.007459:0.006535:0.006535:0.004670:0.008399:0.008399:0.007459:0.004670:0.006535:0.004670:0.003244:0.011205:0.004200:0.011205:0.005594:0.008399:0.006535:0.006535:0.005594
Sectional Study:@0.311647:0.210748:0.417581:0.210748:0.417581:0.194748:0.311647:0.194748:0.009340:0.007459:0.007459:0.004670:0.004670:0.008399:0.008399:0.007459:0.004670:0.004200:0.009340:0.004670:0.008399:0.008399:0.008399
99:@0.896299:0.197271:0.914778:0.197271:0.914778:0.179671:0.896299:0.179671:0.009239:0.009239
Salutary Influence Of Gemifloxacin Mesylate Nanocubosomes Based-In Situ :@0.311647:0.229458:0.835118:0.229458:0.835118:0.213459:0.311647:0.213459:0.009340:0.007459:0.004670:0.008399:0.004670:0.007459:0.005594:0.008399:0.004200:0.005594:0.008399:0.005594:0.004670:0.008399:0.007459:0.008399:0.007459:0.007459:0.004200:0.012129:0.005594:0.004200:0.012129:0.007459:0.013070:0.004670:0.005594:0.004670:0.008399:0.008399:0.007459:0.007459:0.004670:0.008399:0.004200:0.014934:0.007459:0.006535:0.008399:0.004670:0.007459:0.004670:0.007459:0.004200:0.012129:0.007459:0.008399:0.008399:0.007459:0.008399:0.008399:0.008399:0.006535:0.008399:0.013070:0.007459:0.006535:0.004200:0.011205:0.007459:0.006535:0.007459:0.008399:0.005594:0.005594:0.008399:0.004200:0.009340:0.004670:0.004670:0.008399:0.004200
Ocular Gel As A Novel Approach For The Management Of Experimental Keratitis :@0.311647:0.243712:0.869065:0.243712:0.869065:0.227712:0.311647:0.227712:0.012129:0.007459:0.008399:0.004670:0.007459:0.005594:0.004171:0.012129:0.007459:0.004670:0.003244:0.012129:0.006535:0.003254:0.011205:0.004183:0.012129:0.008399:0.008399:0.007459:0.004670:0.003247:0.012129:0.008399:0.008399:0.005594:0.008399:0.007459:0.007459:0.008399:0.004183:0.009340:0.008399:0.005594:0.003876:0.010264:0.008399:0.007459:0.004171:0.014934:0.007459:0.008399:0.007459:0.008399:0.007459:0.013070:0.007459:0.008399:0.004670:0.004163:0.012129:0.005594:0.004183:0.010264:0.008399:0.008399:0.007459:0.005594:0.004670:0.013070:0.007459:0.008399:0.004670:0.007459:0.004670:0.004159:0.012129:0.007459:0.005594:0.007459:0.004670:0.004670:0.004670:0.004670:0.006535:0.004200
Induced By Mrsa:@0.311647:0.257966:0.428282:0.257966:0.428282:0.241966:0.311647:0.241966:0.005594:0.008399:0.008399:0.008399:0.007459:0.007459:0.008399:0.004200:0.011205:0.008399:0.004200:0.014934:0.005594:0.006535:0.007459
100:@0.891679:0.244488:0.919397:0.244488:0.919397:0.226889:0.891679:0.226889:0.009239:0.009239:0.009239
Investigating Fluorogenic Labelling Of Amine Coupled With Firstorder :@0.311647:0.276676:0.796830:0.276676:0.796830:0.260676:0.311647:0.260676:0.005594:0.008399:0.008399:0.007459:0.006535:0.004670:0.004670:0.008399:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.009340:0.004670:0.008399:0.008399:0.005594:0.008399:0.008399:0.007459:0.008399:0.004670:0.007459:0.004200:0.010264:0.007459:0.008399:0.007459:0.004670:0.004670:0.004670:0.008399:0.008399:0.004200:0.012129:0.005594:0.003237:0.012129:0.013070:0.004670:0.008399:0.007459:0.004200:0.011205:0.008399:0.008399:0.008399:0.004670:0.007459:0.008399:0.003886:0.015183:0.004670:0.004670:0.008399:0.004200:0.009340:0.004670:0.005594:0.006535:0.004670:0.008399:0.005594:0.008399:0.007459:0.005594:0.004200
Derivative Spectrofluorimetry As A Versatile Analytical Methodology: :@0.311647:0.290930:0.790487:0.290930:0.790487:0.274930:0.311647:0.274930:0.012129:0.007459:0.005594:0.004670:0.008399:0.007459:0.004670:0.004670:0.008399:0.007459:0.004186:0.009340:0.008399:0.007459:0.007459:0.004670:0.005594:0.008399:0.005594:0.004670:0.008399:0.008399:0.005594:0.004670:0.013070:0.007459:0.004670:0.005594:0.008399:0.003254:0.012129:0.006535:0.003276:0.011205:0.003896:0.010269:0.007459:0.005594:0.006535:0.007459:0.004670:0.004670:0.004670:0.007459:0.003259:0.012129:0.008399:0.007459:0.004670:0.008399:0.004670:0.004670:0.007459:0.007459:0.004670:0.004185:0.014934:0.007459:0.004670:0.008399:0.008399:0.008399:0.008399:0.004670:0.008399:0.008399:0.008399:0.004670:0.004200
Application To Estimation Of Benoxinate In Its Eye Drops:@0.311647:0.305183:0.706759:0.305183:0.706759:0.289184:0.311647:0.289184:0.012129:0.008399:0.008399:0.004670:0.004670:0.007459:0.007459:0.004670:0.004670:0.008399:0.008399:0.003882:0.009088:0.008399:0.004200:0.010264:0.006535:0.004670:0.004670:0.013070:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.012129:0.005594:0.004200:0.011205:0.007459:0.008399:0.008399:0.008399:0.004670:0.008399:0.007459:0.004670:0.007459:0.004200:0.005594:0.008399:0.004200:0.005594:0.004670:0.006535:0.004200:0.010264:0.008399:0.007459:0.004200:0.012129:0.005594:0.008399:0.008399:0.006535
101:@0.891679:0.291706:0.919397:0.291706:0.919397:0.274106:0.891679:0.274106:0.009239:0.009239:0.009239
Formulation Of Lipid Polymer Hybrid Nanoparticles Of The Phytochemical :@0.311647:0.325722:0.827827:0.325722:0.827827:0.309722:0.311647:0.309722:0.009340:0.008399:0.005594:0.013070:0.008399:0.004670:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.012129:0.005594:0.004200:0.010264:0.004670:0.008399:0.004670:0.008399:0.004200:0.009340:0.008399:0.004670:0.008399:0.013070:0.007459:0.005594:0.004200:0.012129:0.008399:0.008399:0.005594:0.004670:0.008399:0.004200:0.012129:0.007459:0.008399:0.008399:0.008399:0.007459:0.005594:0.004670:0.004670:0.007459:0.004670:0.007459:0.006535:0.004200:0.012129:0.005594:0.003864:0.010264:0.008399:0.007459:0.004200:0.009340:0.008399:0.008399:0.004670:0.008399:0.007459:0.008399:0.007459:0.013070:0.004670:0.007459:0.007459:0.004670:0.004200
Fisetin And Its In Vivo Assessment Against Severe Acute Pancreatitis:@0.311647:0.339976:0.779280:0.339976:0.779280:0.323976:0.311647:0.323976:0.009340:0.004670:0.006535:0.007459:0.004670:0.004670:0.008399:0.003267:0.012129:0.008399:0.008399:0.004201:0.005594:0.004670:0.006535:0.004200:0.005594:0.008399:0.003897:0.011123:0.004670:0.008399:0.008399:0.003276:0.012129:0.006535:0.006535:0.007459:0.006535:0.006535:0.013070:0.007459:0.008399:0.004670:0.003276:0.012129:0.008399:0.007459:0.004670:0.008399:0.006535:0.004670:0.004196:0.009340:0.007459:0.008399:0.007459:0.005594:0.007459:0.003276:0.012129:0.007459:0.008399:0.004670:0.007459:0.004193:0.009340:0.007459:0.008399:0.007459:0.005594:0.007459:0.007459:0.004670:0.004670:0.004670:0.004670:0.006535
102:@0.891679:0.333625:0.919397:0.333625:0.919397:0.316025:0.891679:0.316025:0.009239:0.009239:0.009239
Inhibition Of Colorectal Cancer Targets Il-6, Ctla-4, & B7-2 By Tislelizumab: :@0.311647:0.360402:0.840368:0.360402:0.840368:0.344402:0.311647:0.344402:0.005594:0.008399:0.008399:0.004670:0.008399:0.004670:0.004670:0.004670:0.008399:0.008399:0.004200:0.012129:0.005594:0.004200:0.011205:0.008399:0.004670:0.008399:0.005594:0.007459:0.007459:0.004670:0.007459:0.004670:0.004200:0.011205:0.007459:0.008399:0.007459:0.007459:0.005594:0.003864:0.009088:0.007459:0.005288:0.008399:0.007459:0.004670:0.006535:0.004200:0.005594:0.004670:0.005594:0.008399:0.004200:0.004200:0.011205:0.004670:0.004670:0.007459:0.005594:0.008399:0.004200:0.004200:0.013070:0.004200:0.011205:0.008399:0.005594:0.008399:0.004200:0.011205:0.008399:0.003881:0.009671:0.004670:0.006535:0.004670:0.007459:0.004670:0.004670:0.007459:0.008399:0.013070:0.007459:0.008399:0.004670:0.004200
Molecular Docking, Dynamics, & String Proteinprotein Network Analysis:@0.311647:0.374656:0.811341:0.374656:0.811341:0.358656:0.311647:0.358656:0.014934:0.008399:0.004670:0.007459:0.007459:0.008399:0.004670:0.007459:0.005594:0.004200:0.012129:0.008399:0.007459:0.008399:0.004670:0.008399:0.008399:0.004200:0.004200:0.012129:0.008399:0.008399:0.007459:0.013070:0.004670:0.007459:0.006535:0.004200:0.004200:0.013070:0.004200:0.009340:0.004670:0.005594:0.004670:0.008399:0.008399:0.004200:0.009340:0.005594:0.008399:0.004670:0.007459:0.004670:0.008399:0.008399:0.005594:0.008399:0.004670:0.007459:0.004670:0.008399:0.004200:0.012129:0.007459:0.004670:0.012129:0.008399:0.005594:0.008399:0.003235:0.012129:0.008399:0.007459:0.004670:0.008399:0.006535:0.004670:0.006535
103:@0.891679:0.368305:0.919397:0.368305:0.919397:0.350706:0.891679:0.350706:0.009239:0.009239:0.009239
Ai-Driven Discovery Of Celecoxib And Dexamethasone For Exploring Their :@0.311647:0.393848:0.835251:0.393848:0.835251:0.377848:0.311647:0.377848:0.012129:0.004670:0.005594:0.012129:0.005594:0.004670:0.008399:0.007459:0.008399:0.004200:0.012129:0.004670:0.006535:0.007459:0.008399:0.008399:0.007459:0.005594:0.008399:0.004200:0.012129:0.005594:0.004200:0.011205:0.007459:0.004670:0.007459:0.007459:0.008399:0.008399:0.004670:0.008399:0.003257:0.012129:0.008399:0.008399:0.004200:0.012129:0.007459:0.008399:0.007459:0.013070:0.007459:0.004670:0.008399:0.007459:0.006535:0.008399:0.008399:0.007459:0.004200:0.009340:0.008399:0.005594:0.004200:0.010264:0.008399:0.008399:0.004670:0.008399:0.005594:0.004670:0.008399:0.008399:0.003881:0.010264:0.008399:0.007459:0.004670:0.005594:0.004200
Mode Of Action As Human Interleukin(Il-6) Inhibitors To Treat Covid-19-:@0.311647:0.408101:0.813615:0.408101:0.813615:0.392101:0.311647:0.392101:0.014934:0.008399:0.008399:0.007459:0.004200:0.012129:0.005594:0.003276:0.012129:0.007459:0.004670:0.004670:0.008399:0.008399:0.003267:0.012129:0.006535:0.004200:0.012129:0.008399:0.013070:0.007459:0.008399:0.004200:0.005594:0.008399:0.004670:0.007459:0.005594:0.004670:0.007459:0.008399:0.008399:0.004670:0.008399:0.005594:0.005594:0.004670:0.005594:0.008399:0.005594:0.004200:0.005594:0.008399:0.008399:0.004670:0.008399:0.004670:0.004670:0.008399:0.005594:0.006535:0.003879:0.009088:0.008399:0.003896:0.009671:0.005594:0.007459:0.007459:0.004670:0.004200:0.011205:0.008399:0.008399:0.004670:0.008399:0.005594:0.008399:0.008399:0.005594
Induced Cytokine Storm In Humans:@0.311647:0.422355:0.555214:0.422355:0.555214:0.406355:0.311647:0.406355:0.005594:0.008399:0.008399:0.008399:0.007459:0.007459:0.008399:0.004200:0.011205:0.008399:0.004670:0.008399:0.008399:0.004670:0.008399:0.007459:0.004200:0.009340:0.004670:0.008399:0.005594:0.013070:0.004200:0.005594:0.008399:0.004200:0.012129:0.008399:0.013070:0.007459:0.008399:0.006535
104:@0.891679:0.408878:0.919397:0.408878:0.919397:0.391278:0.891679:0.391278:0.009239:0.009239:0.009239
Bioactivity Of Eriocephalus Africanus Essential Oil Against Concanavalin  :@0.311647:0.441996:0.820652:0.441996:0.820652:0.425996:0.311647:0.425996:0.011205:0.004670:0.008399:0.007459:0.007459:0.004670:0.004670:0.008399:0.004670:0.004670:0.008399:0.004200:0.012129:0.005594:0.004200:0.010264:0.005594:0.004670:0.008399:0.007459:0.007459:0.008399:0.008399:0.007459:0.004670:0.008399:0.006535:0.003244:0.012129:0.005594:0.005594:0.004670:0.007459:0.007459:0.008399:0.008399:0.006535:0.004200:0.010264:0.006535:0.006535:0.007459:0.008399:0.004670:0.004670:0.007459:0.004670:0.004200:0.012129:0.004670:0.004670:0.003256:0.012129:0.008399:0.007459:0.004670:0.008399:0.006535:0.004670:0.004200:0.011205:0.008399:0.008399:0.007459:0.007459:0.008399:0.007459:0.008399:0.007459:0.004670:0.004670:0.008399:0.004200:0.004200
A-Induced Hepatitis Via Suppressing Immune Cell Infiltration, Inhibiting Tnf-Α/:@0.311647:0.456249:0.856359:0.456249:0.856359:0.440250:0.311647:0.440250:0.012129:0.005594:0.005594:0.008399:0.008399:0.008399:0.007459:0.007459:0.008399:0.004200:0.012129:0.007459:0.008399:0.007459:0.004670:0.004670:0.004670:0.004670:0.006535:0.003884:0.011123:0.004670:0.007459:0.004200:0.009340:0.008399:0.008399:0.008399:0.005594:0.007459:0.006535:0.006535:0.004670:0.008399:0.008399:0.004200:0.005594:0.013070:0.013070:0.008399:0.008399:0.007459:0.004200:0.011205:0.007459:0.004670:0.004670:0.004200:0.005594:0.008399:0.005594:0.004670:0.004670:0.004670:0.005594:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.004200:0.005594:0.008399:0.008399:0.004670:0.008399:0.004670:0.004670:0.004670:0.008399:0.008399:0.003849:0.010264:0.008399:0.005594:0.005594:0.012129:0.004670
Nf-Κb And Ifn-Γ/Stat1 Signaling Pathways:@0.311647:0.470503:0.603195:0.470503:0.603195:0.454503:0.311647:0.454503:0.012129:0.005594:0.005594:0.012129:0.008399:0.003279:0.012129:0.008399:0.008399:0.004200:0.005594:0.005594:0.008399:0.005594:0.009710:0.004670:0.009340:0.004670:0.007459:0.004670:0.008399:0.004200:0.009340:0.004670:0.008399:0.008399:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.009340:0.007459:0.004670:0.008399:0.012129:0.007459:0.008399:0.006535
105:@0.891679:0.457026:0.919397:0.457026:0.919397:0.439426:0.891679:0.439426:0.009239:0.009239:0.009239
Multi-Targeted Anti-Alzheimer’s Agents: Synthesis, Biological Evaluation, And :@0.311647:0.489863:0.854344:0.489863:0.854344:0.473864:0.311647:0.473864:0.014934:0.008399:0.004670:0.004670:0.004670:0.005594:0.009083:0.007459:0.005288:0.008399:0.007459:0.004670:0.007459:0.008399:0.003264:0.012129:0.008399:0.004670:0.004670:0.005594:0.012129:0.004670:0.007459:0.008399:0.007459:0.004670:0.013070:0.007459:0.006202:0.004667:0.006535:0.003276:0.012129:0.008399:0.007459:0.008399:0.004670:0.006535:0.004670:0.004196:0.009340:0.008399:0.008399:0.004670:0.008399:0.007459:0.006535:0.004670:0.006535:0.004200:0.004200:0.011205:0.004670:0.008399:0.004670:0.008399:0.008399:0.004670:0.007459:0.007459:0.004670:0.004183:0.010264:0.008399:0.007459:0.004670:0.008399:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.003257:0.012129:0.008399:0.008399:0.004200
Molecular Modeling Study Of Some Pyrazolopyridine Hybrids:@0.311647:0.504117:0.736256:0.504117:0.736256:0.488117:0.311647:0.488117:0.014934:0.008399:0.004670:0.007459:0.007459:0.008399:0.004670:0.007459:0.005594:0.004200:0.014934:0.008399:0.008399:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.009340:0.004670:0.008399:0.008399:0.008399:0.004200:0.012129:0.005594:0.004200:0.009340:0.008399:0.013070:0.007459:0.004200:0.009340:0.008399:0.005594:0.007459:0.007459:0.008399:0.004670:0.008399:0.008399:0.008399:0.005594:0.004670:0.008399:0.004670:0.008399:0.007459:0.004200:0.012129:0.008399:0.008399:0.005594:0.004670:0.008399:0.006535
106:@0.891679:0.497767:0.919397:0.497767:0.919397:0.480167:0.891679:0.480167:0.009239:0.009239:0.009239
New 2-Alkoxycyanopyridine Derivatives As Inhibitors Of EGFR, HER2, And :@0.311647:0.525217:0.841213:0.525217:0.841213:0.509217:0.311647:0.509217:0.012129:0.007459:0.012129:0.004200:0.008399:0.005594:0.012129:0.004670:0.008399:0.008399:0.008399:0.008399:0.007459:0.008399:0.007459:0.008399:0.008399:0.008399:0.008399:0.005594:0.004670:0.008399:0.004670:0.008399:0.007459:0.004200:0.012129:0.007459:0.005594:0.004670:0.008399:0.007459:0.004670:0.004670:0.008399:0.007459:0.006535:0.003252:0.012129:0.006535:0.004200:0.005594:0.008399:0.008399:0.004670:0.008399:0.004670:0.004670:0.008399:0.005594:0.006535:0.004200:0.012129:0.005594:0.004200:0.010264:0.012129:0.009340:0.011205:0.004200:0.004200:0.012129:0.010264:0.011205:0.008399:0.004200:0.003279:0.012129:0.008399:0.008399:0.004200
DHFR: Synthesis, Anticancer Evaluation, And Molecular Modeling Studies:@0.311647:0.539470:0.820708:0.539470:0.820708:0.523471:0.311647:0.523471:0.012129:0.012129:0.009340:0.011205:0.004670:0.004200:0.009340:0.008399:0.008399:0.004670:0.008399:0.007459:0.006535:0.004670:0.006535:0.004200:0.003277:0.012129:0.008399:0.004670:0.004670:0.007459:0.007459:0.008399:0.007459:0.007459:0.005594:0.004200:0.010264:0.008399:0.007459:0.004670:0.008399:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.003244:0.012129:0.008399:0.008399:0.004200:0.014934:0.008399:0.004670:0.007459:0.007459:0.008399:0.004670:0.007459:0.005594:0.004200:0.014934:0.008399:0.008399:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.009340:0.004670:0.008399:0.008399:0.004670:0.007459:0.006535
107:@0.891679:0.533120:0.919397:0.533120:0.919397:0.515520:0.891679:0.515520:0.009239:0.009239:0.009239
Tetraenone A: A New Β-Ionone Derivative From Tetraena Aegyptia:@0.311647:0.560963:0.766160:0.560963:0.766160:0.544963:0.311647:0.544963:0.009088:0.007459:0.004670:0.005594:0.007459:0.007459:0.008399:0.008399:0.008399:0.007459:0.003261:0.012129:0.004670:0.003272:0.011205:0.004200:0.012129:0.007459:0.012129:0.004200:0.011205:0.005594:0.005594:0.008399:0.008399:0.008399:0.008399:0.007459:0.004200:0.012129:0.007459:0.005594:0.004670:0.008399:0.007459:0.004670:0.004670:0.008399:0.007459:0.004200:0.009340:0.005594:0.008399:0.013070:0.003884:0.009088:0.007459:0.004670:0.005594:0.007459:0.007459:0.008399:0.007459:0.003259:0.012129:0.007459:0.008399:0.008399:0.008399:0.004670:0.004670:0.007459
108:@0.891679:0.561740:0.919397:0.561740:0.919397:0.544140:0.891679:0.544140:0.009239:0.009239:0.009239
Repurposing Synthetic Congeners Of A Natural Product Aurone Unveils A Lead :@0.311647:0.580716:0.855208:0.580716:0.855208:0.564717:0.311647:0.564717:0.011205:0.007459:0.008399:0.008399:0.005594:0.008399:0.008399:0.006535:0.004670:0.008399:0.008399:0.004200:0.009340:0.008399:0.008399:0.004670:0.008399:0.007459:0.004670:0.004670:0.007459:0.004200:0.011205:0.008399:0.008399:0.008399:0.007459:0.008399:0.007459:0.005594:0.006535:0.004200:0.012129:0.005594:0.003259:0.011205:0.004200:0.012129:0.007459:0.004670:0.008399:0.005594:0.007459:0.004670:0.004200:0.009340:0.005594:0.008399:0.008399:0.008399:0.007459:0.004670:0.003262:0.012129:0.008399:0.005594:0.008399:0.008399:0.007459:0.004200:0.012129:0.008399:0.008399:0.007459:0.004670:0.004670:0.006535:0.003271:0.011205:0.004200:0.010264:0.007459:0.007459:0.008399:0.004200
Antitumor Agent Inhibiting Folded P-Loop Conformation Of Met Receptor :@0.311647:0.594970:0.822591:0.594970:0.822591:0.578970:0.311647:0.578970:0.012129:0.008399:0.004670:0.004670:0.004670:0.008399:0.013070:0.008399:0.005594:0.003264:0.012129:0.008399:0.007459:0.008399:0.004670:0.004200:0.005594:0.008399:0.008399:0.004670:0.008399:0.004670:0.004670:0.004670:0.008399:0.008399:0.004200:0.009340:0.008399:0.004670:0.008399:0.007459:0.008399:0.004200:0.009340:0.005594:0.010264:0.008399:0.008399:0.008399:0.004200:0.011205:0.008399:0.008399:0.005594:0.008399:0.005594:0.013070:0.007459:0.004670:0.004670:0.008399:0.008399:0.004200:0.012129:0.005594:0.004200:0.014934:0.007459:0.004670:0.004200:0.011205:0.007459:0.007459:0.007459:0.008399:0.004670:0.008399:0.005594:0.004200
Tyrosine Kinase:@0.311647:0.609224:0.421041:0.609224:0.421041:0.593224:0.311647:0.593224:0.009088:0.008399:0.005594:0.008399:0.006535:0.004670:0.008399:0.007459:0.004200:0.012129:0.004670:0.008399:0.007459:0.006535:0.007459
109:@0.891679:0.595746:0.919397:0.595746:0.919397:0.578147:0.891679:0.578147:0.009239:0.009239:0.009239
Design, Synthesis, And Repurposing Of Rosmarinic Acid-Β-Amino-Α Ketoamide :@0.311647:0.628247:0.865976:0.628247:0.865976:0.612247:0.311647:0.612247:0.012129:0.007459:0.006535:0.004670:0.008399:0.008399:0.004200:0.004200:0.009340:0.008399:0.008399:0.004670:0.008399:0.007459:0.006535:0.004670:0.006535:0.004200:0.003272:0.012129:0.008399:0.008399:0.004200:0.011205:0.007459:0.008399:0.008399:0.005594:0.008399:0.008399:0.006535:0.004670:0.008399:0.008399:0.004200:0.012129:0.005594:0.004200:0.011205:0.008399:0.006535:0.013070:0.007459:0.005594:0.004670:0.008399:0.004670:0.007459:0.003266:0.012129:0.007459:0.004670:0.008399:0.005594:0.011205:0.005594:0.012129:0.013070:0.004670:0.008399:0.008399:0.005594:0.011200:0.004200:0.012129:0.007459:0.004670:0.008399:0.007459:0.013070:0.004670:0.008399:0.007459:0.004200
Hybrids As Antileishmanial Agents:@0.311647:0.642501:0.549158:0.642501:0.549158:0.626501:0.311647:0.626501:0.012129:0.008399:0.008399:0.005594:0.004670:0.008399:0.006535:0.003276:0.012129:0.006535:0.003276:0.012129:0.008399:0.004670:0.004670:0.004670:0.007459:0.004670:0.006535:0.008399:0.013070:0.007459:0.008399:0.004670:0.007459:0.004670:0.003251:0.012129:0.008399:0.007459:0.008399:0.004670:0.006535
110:@0.892022:0.636150:0.919057:0.636150:0.919057:0.618551:0.892022:0.618551:0.008556:0.009239:0.009239
Design, Synthesis, In Vitro, And In Silico Studies Of New N5 Substituted-:@0.311647:0.661917:0.812431:0.661917:0.812431:0.645918:0.311647:0.645918:0.012129:0.007459:0.006535:0.004670:0.008399:0.008399:0.004200:0.004200:0.009340:0.008399:0.008399:0.004670:0.008399:0.007459:0.006535:0.004670:0.006535:0.004200:0.004200:0.005594:0.008399:0.003896:0.011123:0.004670:0.004670:0.005594:0.008399:0.004200:0.003267:0.012129:0.008399:0.008399:0.004200:0.005594:0.008399:0.004200:0.009340:0.004670:0.004670:0.004670:0.007459:0.008399:0.004200:0.009340:0.004670:0.008399:0.008399:0.004670:0.007459:0.006535:0.004200:0.012129:0.005594:0.004200:0.012129:0.007459:0.012129:0.004200:0.012129:0.008399:0.004200:0.009340:0.008399:0.008399:0.006535:0.004670:0.004670:0.004670:0.008399:0.004670:0.007459:0.008399:0.005594
Pyrazolo[3,4-D]Pyrimidinone Derivatives As Anticancer Cdk2 Inhibitors:@0.311647:0.676171:0.803412:0.676171:0.803412:0.660171:0.311647:0.660171:0.009340:0.008399:0.005594:0.007459:0.007459:0.008399:0.004670:0.008399:0.005594:0.008399:0.004200:0.008399:0.005594:0.012129:0.005594:0.009340:0.008399:0.005594:0.004670:0.013070:0.004670:0.008399:0.004670:0.008399:0.008399:0.008399:0.007459:0.004200:0.012129:0.007459:0.005594:0.004670:0.008399:0.007459:0.004670:0.004670:0.008399:0.007459:0.006535:0.003249:0.012129:0.006535:0.003279:0.012129:0.008399:0.004670:0.004670:0.007459:0.007459:0.008399:0.007459:0.007459:0.005594:0.004200:0.011205:0.008399:0.008399:0.008399:0.004200:0.005594:0.008399:0.008399:0.004670:0.008399:0.004670:0.004670:0.008399:0.005594:0.006535
111:@0.892365:0.669820:0.918716:0.669820:0.918716:0.652221:0.892365:0.652221:0.008556:0.008556:0.009239
Vision, Mision And Strategic Goals:@0.311647:0.697158:0.550959:0.697158:0.550959:0.681159:0.311647:0.681159:0.011123:0.004670:0.006535:0.004670:0.008399:0.008399:0.004200:0.004200:0.014934:0.004670:0.006535:0.004670:0.008399:0.008399:0.003269:0.012129:0.008399:0.008399:0.004200:0.009340:0.004670:0.005594:0.007459:0.004670:0.007459:0.008399:0.004670:0.007459:0.004200:0.012129:0.008399:0.007459:0.004670:0.006535
112:@0.892022:0.697935:0.919057:0.697935:0.919057:0.680335:0.892022:0.680335:0.008556:0.009239:0.009239
Editorial Board:@0.311647:0.718534:0.415699:0.718534:0.415699:0.702535:0.311647:0.702535:0.010264:0.008399:0.004670:0.004670:0.008399:0.005594:0.004670:0.007459:0.004670:0.004200:0.011205:0.008399:0.007459:0.005594:0.008399
113:@0.892022:0.719311:0.919057:0.719311:0.919057:0.701711:0.892022:0.701711:0.008556:0.009239:0.009239